JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women

  • 0Department of Clinical Biochemistry, Herlev University Hospital, Herlev, Denmark. brno@heh.regionh.dk
Jama +

|

July 20, 2007

|

July 20, 2007

Related Experiment Videos

Contact us if these videos are not relevant.

View abstract on PubMed

Summary

This summary is machine-generated.

Elevated nonfasting triglycerides significantly increase the risk of myocardial infarction (MI), ischemic heart disease (IHD), and death in both men and women. This study highlights the importance of monitoring triglyceride levels for cardiovascular health.

Area Of Science

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Epidemiology

Background

  • Elevated nonfasting triglycerides are linked to remnant lipoproteins, which may contribute to atherosclerosis.
  • Understanding the prognostic value of nonfasting triglyceride levels is crucial for cardiovascular risk assessment.

Purpose Of The Study

  • To investigate the association between very high nonfasting triglyceride levels and the risk of myocardial infarction (MI), ischemic heart disease (IHD), and all-cause mortality.
  • To test the hypothesis that elevated nonfasting triglycerides predict adverse cardiovascular outcomes.

Main Methods

  • A prospective cohort study involving 7587 women and 6394 men from the general population of Copenhagen, Denmark.
  • Participants were followed from baseline (1976-1978) to 2004, with hazard ratios (HRs) calculated for MI, IHD, and death across different nonfasting triglyceride level categories.
  • Statistical analyses included age-adjusted and multifactorially adjusted hazard ratios (aHRs) to assess risk across increasing triglyceride levels.

Main Results

  • Increasing nonfasting triglyceride levels correlated with higher levels of remnant lipoprotein cholesterol.
  • During a mean follow-up of 26 years, significant associations were found between elevated nonfasting triglycerides and increased risk of MI, IHD, and death in both sexes.
  • For example, in women, the adjusted HR for MI increased substantially with higher triglyceride categories, reaching 5.4 for levels ≥5 mmol/L.
  • Similar trends were observed in men, with adjusted HRs for MI reaching 2.4 for the highest triglyceride category.

Conclusions

  • Elevated nonfasting triglyceride levels are a significant independent risk factor for myocardial infarction, ischemic heart disease, and overall mortality in the general population.
  • These findings underscore the clinical importance of assessing nonfasting triglyceride levels for comprehensive cardiovascular risk stratification.

Related Experiment Videos

Contact us if these videos are not relevant.

Related Concept Videos